Semaglutide Price 2026: What You'll Actually Pay

Semaglutide price at a glance (2026)

The price of semaglutide depends entirely on which version you buy and where. The same molecule can cost you $149 or $1,349 per month. Here is the full landscape before we break down each option:

If you are paying out of pocket, the difference between the best and worst option is over $1,200 per month, or $14,000+ per year. This guide shows you exactly where the savings are.

Brand-name semaglutide prices: Wegovy, Ozempic, Rybelsus

Novo Nordisk makes all three FDA-approved semaglutide products. List prices (what pharmacies charge without insurance or discounts) as of 2026:

• Wegovy: $1,349.02 per month at list price. This is the only semaglutide FDA-approved specifically for chronic weight management. All four maintenance doses (0.25 mg through 2.4 mg) cost the same.
• Ozempic: $997.58 per month at list. Approved for type 2 diabetes but widely prescribed off-label for weight loss. Same drug, same doses up to 2 mg, roughly $350 cheaper than Wegovy.
• Rybelsus: $997.58 per month at list. The oral tablet version (7 mg or 14 mg daily). Weaker weight loss results than injections, but an option for needle-averse patients.

Almost nobody should pay list price. Between NovoCare, savings cards, insurance, and compounded alternatives, there is always a cheaper path.

NovoCare Pharmacy: the $499 game changer

In 2025, Novo Nordisk launched NovoCare Pharmacy, a direct-to-consumer channel selling Wegovy and Ozempic for $499 per month to cash-pay patients. No insurance required, no savings card needed. You still need a prescription, but any licensed provider can write one, including telehealth services.

This was a direct response to Eli Lilly's Zepbound at $499 to $649 through LillyDirect, and to the compounded semaglutide market eating their lunch. For patients who want brand-name medication without insurance, $499 is now the benchmark price to beat.

Compounded semaglutide: $149 to $299 per month

Compounded semaglutide is prepared by state-licensed compounding pharmacies and prescribed through telehealth weight loss programs. It contains the same active ingredient, typically combined with vitamin B12 or glycine, and costs a fraction of brand pricing:

The trade-off: compounded semaglutide is not FDA-approved. Quality depends on the pharmacy. Stick with providers that use accredited 503A or 503B compounding facilities and publish their pharmacy partners. Our telehealth comparison breaks down which programs meet that bar.

Semaglutide price by pharmacy (brand-name)

If you have a brand-name prescription and pay cash, retail pharmacy prices cluster near list price with minor variation:

The lesson: retail pharmacy prices barely differ. The real savings come from NovoCare, insurance, savings cards, or compounded alternatives, not from shopping between CVS and Walgreens.

What you will pay with insurance

With commercial insurance, your out-of-pocket cost depends on whether your plan covers anti-obesity medications:

• Covered with savings card: $0 to $25/month. The Wegovy and Ozempic savings cards reduce copays dramatically for eligible commercially-insured patients.
• Covered without savings card: $25 to $300/month depending on your copay tier and deductible status.
• Not covered: Full list price, or $499 through NovoCare, or $149+ compounded.

Medicare does not cover weight loss medications (though it covers Ozempic for diabetes). Medicaid coverage varies by state. If your claim is denied, a prior authorization appeal succeeds roughly 30 to 40% of the time with proper documentation.

Hidden costs to factor in

The sticker price is not the whole story. Budget for:

• Provider visits: Telehealth programs bundle this; traditional routes may charge $50 to $200 per consultation.
• Lab work: Baseline and monitoring labs run $50 to $150 if not included in your program.
• Dose escalation: Compounded pricing sometimes increases at higher doses. Ask before you sign up.
• Supplies: Brand pens include needles; compounded vials may require purchasing syringes ($10 to $20/month).

Where semaglutide prices are heading

The trend is clearly downward. Novo Nordisk and Eli Lilly are in a price war, oral GLP-1s like Foundayo are expanding the market, and political pressure on drug pricing continues. Analysts project brand-name cash prices settling in the $350 to $500 range by 2027, while compounded options hold near $149 to $199.

The worst strategy is waiting for prices to drop further while delaying treatment. The best strategy is starting with the most affordable legitimate option now and switching later if prices fall.

Bottom line: the cheapest legitimate path

If you have insurance that covers GLP-1s, use it plus the savings card and pay $0 to $25. If you are paying cash and want brand-name, NovoCare at $499 is your floor. If you want the lowest price, compounded semaglutide through a reputable telehealth program starts at $149 to $199 per month with everything included.

Compare current program pricing and eligibility in our 2026 telehealth comparison, or check your options directly:

Related GLP-1 guides

• Semaglutide Cost Breakdown
• Semaglutide Cost Per Month
• Wegovy Cost 2026
• Ozempic Cost 2026
• Cheapest Compounded Semaglutide
• GLP-1 Manufacturer Savings Cards
• GLP-1 GoodRx Discounts
• GLP-1 Cost Without Insurance
• FSA/HSA Eligibility for GLP-1
• Best GLP-1 Telehealth Programs
• Compounded vs Brand GLP-1
• NovoCare Wegovy Guide
• GLP-1 Price Tracker 2026
• HSA/FSA for GLP-1